Gal11 activators form a specialized class of compounds aimed at enhancing the activity of Gal11, a key protein component within the mediator complex that plays a crucial role in the regulation of transcription by RNA polymerase II. The discovery and development of these activators are based on an intricate understanding of Gal11's interaction with other components of the mediator complex and its role in facilitating the assembly of transcription factors and RNA polymerase II at gene promoters. Identifying potential activators typically begins with high-throughput screening (HTS) techniques, which test a vast array of compounds for their ability to increase Gal11's activity or its interaction with the mediator complex and RNA polymerase II. This screening seeks to isolate molecules that can bind to Gal11 and enhance its role in the transcription process, thereby promoting gene expression. Following the identification of promising compounds, structure-activity relationship (SAR) studies are undertaken to refine these initial hits. SAR analysis involves methodical modifications to the compounds' chemical structures, assessing how these alterations affect their ability to activate Gal11. Through these studies, researchers aim to improve the potency and specificity, ensuring they are effective in specifically enhancing Gal11 function.
The development process for Gal11 activators also incorporates advanced analytical techniques, such as X-ray crystallography and nuclear magnetic resonance (NMR) spectroscopy, to gain detailed insights into the molecular interactions between Gal11 and the activator compounds. These structural analyses are invaluable for understanding the basis of activation at the atomic level, facilitating the rational design of more effective activators. Furthermore, cellular assays play a critical role in validating the activators' efficacy in a biological context, ensuring that they can indeed enhance Gal11-mediated transcription activation within living cells. These assays not only confirm the activators' ability to promote gene expression but also help elucidate the biological implications of increased Gal11 activity. Through this comprehensive approach, combining chemical synthesis with detailed structural and functional assays, Gal11 activators are meticulously developed to precisely modulate gene expression. This targeted modulation provides insights into the regulation of transcription and offers a foundation for further exploration of the mediator complex's role in cellular processes.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
D-Galactose | 59-23-4 | sc-202564 | 100 g | $288.00 | 4 | |
As the specific inducer of the GAL gene pathway, galactose may upregulate Gal11/Med15 as part of the pathway activation. | ||||||
2-Deoxy-D-glucose | 154-17-6 | sc-202010 sc-202010A | 1 g 5 g | $70.00 $215.00 | 26 | |
This glucose analog interferes with glycolysis and may induce Gal11/Med15 expression as the cell attempts to regulate carbohydrate metabolism genes. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
An inhibitor of the TOR signaling pathway, rapamycin may indirectly increase Gal11/Med15 expression by affecting growth-related gene expression. | ||||||
D(+)Glucose, Anhydrous | 50-99-7 | sc-211203 sc-211203B sc-211203A | 250 g 5 kg 1 kg | $38.00 $198.00 $65.00 | 5 | |
High glucose concentrations may repress GAL gene expression, but fluctuations or depletion could lead to induction of Gal11/Med15 as part of a compensatory response. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
An HDAC inhibitor, sodium butyrate affects chromatin structure and gene expression and could indirectly induce Gal11/Med15 expression. | ||||||
Hydroxyurea | 127-07-1 | sc-29061 sc-29061A | 5 g 25 g | $78.00 $260.00 | 18 | |
By inhibiting DNA replication, hydroxyurea can stress cells, potentially leading to changes in gene expression, including that of Gal11/Med15. | ||||||
Vitamin K3 | 58-27-5 | sc-205990B sc-205990 sc-205990A sc-205990C sc-205990D | 5 g 10 g 25 g 100 g 500 g | $26.00 $36.00 $47.00 $136.00 $455.00 | 3 | |
A redox-cycling compound that generates reactive oxygen species and could stress cells, possibly affecting Gal11/Med15 expression. | ||||||
Methyl methanesulfonate | 66-27-3 | sc-250376 sc-250376A | 5 g 25 g | $56.00 $133.00 | 2 | |
As a DNA-damaging agent, MMS may induce a variety of stress responses, potentially including the upregulation of Gal11/Med15. | ||||||
Acetic acid | 64-19-7 | sc-214462 sc-214462A | 500 ml 2.5 L | $63.00 $106.00 | 5 | |
As a carbon source in some metabolic conditions, acetate could induce Gal11/Med15 as yeast cells switch to oxidative metabolism. | ||||||